UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

Leukemia, 2017-11, Vol.31 (11), p.2398-2406

2017

Volltextzugriff (PDF)

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)

Leukemia, 2012-09, Vol.26 (9), p.2096-2102

2012

Volltextzugriff (PDF)

Lack of telomerase activity in human mesenchymal stem cells

Leukemia, 2003-06, Vol.17 (6), p.1146-1149

2003

Volltextzugriff (PDF)

Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group

Annals of oncology, 2008-03, Vol.19 (3), p.448-453

2008

Volltextzugriff (PDF)

Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors

Leukemia, 2013-01, Vol.27 (1), p.118-129

2013

Volltextzugriff (PDF)

Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib

Leukemia, 2014-10, Vol.28 (10), p.1988-1992

2014

Volltextzugriff (PDF)

Medicinal tumor treatment of oropharyngeal cancer

HNO, 2021-04, Vol.69 (4), p.285-297

2021

Volltextzugriff (PDF)

Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)

Annals of oncology, 2015-08, Vol.26 (8), p.1734-1740

2015

Volltextzugriff (PDF)

Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognostic Index

Annals of oncology, 2004-09, Vol.15 (9), p.1419-1424

2004

Volltextzugriff (PDF)

Long-term remission after CD34 -selected PBSCT in a patient with advanced intra-abdominal desmoplastic small round-cell tumor

Bone marrow transplantation (Basingstoke), 2010-04, Vol.45 (4), p.793-795

2010

Volltextzugriff (PDF)

Medikamentöse Therapie des Oropharynxkarzinoms

HNO, 2021-04, Vol.69 (4), p.285-297

2021

Volltextzugriff (PDF)

High- Versus Standard-Dose Filgrastim (rhG-CSF) for Mobilization of Peripheral-Blood Progenitor Cells From Allogeneic Donors and CD34+ Immunoselection

Journal of clinical oncology, 1999-07, Vol.17 (7), p.2160-2172

1999

Volltextzugriff (PDF)

Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions

Annals of hematology, 2002-05, Vol.81 (5), p.273-281

2002

Volltextzugriff (PDF)

Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantation

Bone marrow transplantation (Basingstoke), 2004-09, Vol.34 (6), p.515-519

2004

Volltextzugriff (PDF)

Application of the optimized CO-rebreathing method for determination of hemoglobin mass in patients with polycythemia vera

Annals of hematology, 2014-07, Vol.93 (7), p.1159-1165

2014

Volltextzugriff (PDF)

P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG‐0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA

HemaSphere, 2022-06, Vol.6 (Suppl), p.945-946

2022

Volltextzugriff (PDF)

Bone marrow changes in chronic myelogenous leukaemia after long-term treatment with the tyrosine kinase inhibitor STI571: an immunohistochemical study on 75 patients

Histopathology, 2005-05, Vol.46 (5), p.540-550

2005

Volltextzugriff (PDF)

Malignant pleural mesothelioma

Deutsche medizinische Wochenschrift (1946), 2012-03, Vol.137 (10), p.481

2012

Volltextzugriff (PDF)

Stereotactic ablative radiotherapy for small lung tumors with a moderate dose: Favorable results and low toxicity

Strahlentherapie und Onkologie, 2013, Vol.189 (1), p.33-40

2013

Volltextzugriff (PDF)

Treatment-related chronic myelogenous leukemia

Annals of hematology, 1999-08, Vol.78 (8), p.341-354

1999

Volltextzugriff (PDF)

Mobilization of peripheral blood progenitor cells for allogeneic transplantation : efficacy and toxicity of a high-dose rhG-CSF regimen

Bone marrow transplantation (Basingstoke), 1996-08, Vol.18 (2), p.279-283

1996

Volltextzugriff (PDF)

Mobilization of peripheral blood progenitor cells in patients with breast cancer : A prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy

Bone marrow transplantation (Basingstoke), 1999-07, Vol.24 (1), p.19-24

1999

Volltextzugriff (PDF)

Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial

Haematologica (Roma), 2016-09, Vol.101 (9), p.1065

2016

Volltextzugriff (PDF)

Generation of dendritic cells from patients with chronic myelogenous leukemia

Annals of hematology, 1999-04, Vol.78 (4), p.181-186

1999

Volltextzugriff (PDF)

Secondary chronic myelogenous leukemia after chemotherapy followed by adjuvant radiotherapy for small cell lung cancer

Leukemia research, 1999-10, Vol.23 (10), p.961-964

1999

Volltextzugriff (PDF)

1 – 25 von 944

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(817)
Mit Volltextzugriff
(825)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)

Lack of telomerase activity in human mesenchymal stem cells

Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group

Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors

Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib

Medicinal tumor treatment of oropharyngeal cancer

Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)

Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognostic Index

Long-term remission after CD34 -selected PBSCT in a patient with advanced intra-abdominal desmoplastic small round-cell tumor

Medikamentöse Therapie des Oropharynxkarzinoms

High- Versus Standard-Dose Filgrastim (rhG-CSF) for Mobilization of Peripheral-Blood Progenitor Cells From Allogeneic Donors and CD34+ Immunoselection

Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions

Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantation

Application of the optimized CO-rebreathing method for determination of hemoglobin mass in patients with polycythemia vera

P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG‐0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA

Bone marrow changes in chronic myelogenous leukaemia after long-term treatment with the tyrosine kinase inhibitor STI571: an immunohistochemical study on 75 patients

Malignant pleural mesothelioma

Stereotactic ablative radiotherapy for small lung tumors with a moderate dose: Favorable results and low toxicity

Treatment-related chronic myelogenous leukemia

Mobilization of peripheral blood progenitor cells for allogeneic transplantation : efficacy and toxicity of a high-dose rhG-CSF regimen

Mobilization of peripheral blood progenitor cells in patients with breast cancer : A prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy

Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial

Generation of dendritic cells from patients with chronic myelogenous leukemia

Secondary chronic myelogenous leukemia after chemotherapy followed by adjuvant radiotherapy for small cell lung cancer

Suchergebnisse filtern